DNAprint Genomics (DNAG)

[frogdreaming]

No bag, it t'wouldn't.

It is certainly an exaggeration, but it is not clearly false.

It can be argued that some revenues are generated by the sale of a few DNAWitness and/or Ancestry kits, but since both of those products cost more money to process than they return, it is only through accounting 'sleight of hand' that they could be considered revenue at all.

ALL revenues in excess of expenses are generated through the sale of shares. All capital needed to compensate management is generated through the sale of shares. All of the money neccessary to fund those acquisitions on which the future of the company is dependent are generated through the sale of shares.

T'would be hard to argue that the pps is not an integral part of the future of the company and that the company's fate is not directly tied to the pps, t'wouldn't it?

regards,
frog